BR9406814A - Concentrado de imunoglobulinas g de uso terapêutico e processo de produção do referido concentrado - Google Patents

Concentrado de imunoglobulinas g de uso terapêutico e processo de produção do referido concentrado

Info

Publication number
BR9406814A
BR9406814A BR9406814-3A BR9406814A BR9406814A BR 9406814 A BR9406814 A BR 9406814A BR 9406814 A BR9406814 A BR 9406814A BR 9406814 A BR9406814 A BR 9406814A
Authority
BR
Brazil
Prior art keywords
concentrate
immunoglobulin
therapeutic use
production process
relates
Prior art date
Application number
BR9406814-3A
Other languages
English (en)
Inventor
Miryana Burnouf
Dominique Dernis
Patrick Bonneel
Thierry Burnouf
Original Assignee
Aetsrn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aetsrn filed Critical Aetsrn
Publication of BR9406814A publication Critical patent/BR9406814A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Patente de Invenção: "CONCENTRADO DE IMUNOGLOBULINAS G DE USO TERAPêUTICO E PROCESSO DE PRODUçãO DO REFERIDO CONCENTRADO". A invenção é relativa a um concentrado de imunoglobulinas G de origem plásmática e seu processo de produção. Este compreende uma sucessão de separações cromatográficas mas não precipitação com etanol. O processo compreende, além disso, um tratamento de inativação viral. A invenção é relativa igualmente ao concentrado de imunoglobulinas G obtido pelo referido processo e cuja qualidade é apropriada para qualquer uso terapêutico, em particular para injeção por via intra-venosa.
BR9406814-3A 1993-06-14 1994-06-13 Concentrado de imunoglobulinas g de uso terapêutico e processo de produção do referido concentrado BR9406814A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9307128A FR2706466B1 (fr) 1993-06-14 1993-06-14 Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
PCT/FR1994/000699 WO1994029334A1 (fr) 1993-06-14 1994-06-13 Concentre d'immunoglobulines g a usage therapeutique et procede de production dudit concentre

Publications (1)

Publication Number Publication Date
BR9406814A true BR9406814A (pt) 2000-05-30

Family

ID=9448094

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9406814-3A BR9406814A (pt) 1993-06-14 1994-06-13 Concentrado de imunoglobulinas g de uso terapêutico e processo de produção do referido concentrado

Country Status (16)

Country Link
US (1) US6069236A (pt)
EP (1) EP0703922B1 (pt)
JP (1) JP4218980B2 (pt)
AT (1) ATE193020T1 (pt)
AU (1) AU7002394A (pt)
BR (1) BR9406814A (pt)
CA (1) CA2165203C (pt)
CZ (1) CZ287186B6 (pt)
DE (1) DE69424545T2 (pt)
DK (1) DK0703922T3 (pt)
ES (1) ES2148332T3 (pt)
FR (1) FR2706466B1 (pt)
GR (1) GR3034177T3 (pt)
HU (1) HU218463B (pt)
PT (1) PT703922E (pt)
WO (1) WO1994029334A1 (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2270044T3 (en) * 1998-06-09 2015-01-26 Csl Behring Ag Liquid immunoglobulin G (IgG) product
ID27417A (id) * 1998-06-09 2001-04-05 Statens Seruminstitut Proses untuk memproduksi immunoglobulin untuk pemberian melalui intravena dan produk-produk immunoglobulin lainnya
US6962700B1 (en) 2000-09-13 2005-11-08 Atopix Pharmaceuticals Corporation Method of manufacturing immune globulin
FR2824568B1 (fr) * 2001-05-11 2004-04-09 Lab Francais Du Fractionnement Procede de preparation de concentres d'immunoglobulines humaines a usage therapeutique
US20060104968A1 (en) 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
US7932365B2 (en) 2003-11-08 2011-04-26 Pro Thera Biologics, Llc Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
EP1532983A1 (en) 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
TWI391399B (zh) 2005-05-25 2013-04-01 赫孚孟拉羅股份公司 測定溶離多肽之鹽濃度之方法
FR2895263B1 (fr) 2005-12-26 2008-05-30 Lab Francais Du Fractionnement Concentre d'immunoglobines g (lg) appauvri en anticorps anti-a et anti-b, et en igg polyreactives
WO2007136327A1 (en) * 2006-05-22 2007-11-29 Ge Healthcare Bio-Sciences Ab A method of producing igg
TWI489994B (zh) 2008-03-17 2015-07-01 Baxter Healthcare Sa 供免疫球蛋白及玻尿酸酶之皮下投藥之用的組合及方法
JP5793076B2 (ja) 2008-05-28 2015-10-14 プロセラ バイオロジクス， インコーポレイテッド 血液由来インター−アルファ−阻害タンパク質の調製及び組成物。
FR2939667B1 (fr) 2008-12-17 2012-01-27 Fractionnement Et Des Biotechonologies Lab Franc Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo
US8546548B2 (en) 2009-05-27 2013-10-01 Baxter International Inc. Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
US20100322943A1 (en) 2009-06-17 2010-12-23 Thomas Cantor Therapeutic and diagnostic affinity purified specific polyclonal antibodies
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
PT2477603E (pt) 2009-09-17 2016-06-16 Baxalta Inc Co-formulação estável de hialuronidase e imunoglobulina e métodos para a sua utilização
IT1397061B1 (it) 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
DK2531218T3 (en) 2010-02-04 2019-04-01 Csl Behring Ag immunoglobulin
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
RU2649363C2 (ru) 2010-11-16 2018-04-02 Октафарма Аг СПОСОБЫ СНИЖЕНИЯ И/ИЛИ УДАЛЕНИЯ FXI и FXIa ИЗ РАСТВОРОВ, СОДЕРЖАЩИХ УКАЗАННЫЕ ФАКТОРЫ СВЕРТЫВАНИЯ
AU2011350895B2 (en) 2010-12-30 2015-05-28 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Glycols as pathogen inactivating agents
FR2974301B1 (fr) 2011-04-20 2013-08-23 Lab Francais Du Fractionnement Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes
ES2647925T3 (es) * 2011-05-12 2017-12-27 Csl Behring Gmbh Métodos para reducir los eventos adversos causados por preparados farmacéuticos que comprenden proteínas derivadas del plasma
FR2977893B1 (fr) 2011-07-11 2015-02-20 Lab Francais Du Fractionnement Procede de preparation d'un concentre d'immunoglobulines polyvalentes
CA2846599A1 (en) 2011-08-26 2013-03-07 Baxter International Inc. Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之ｉ-ｉｖ-１部分沉澱
FI3590960T3 (fi) 2012-02-29 2023-04-25 Takeda Pharmaceuticals Co Perifeeristen hermojen IgG-stimuloitu remyelinaatio
EP2636681A1 (en) 2012-03-09 2013-09-11 CSL Behring AG Process for enriching IgA
EP2636684A1 (en) 2012-03-09 2013-09-11 CSL Behring AG Prevention of infection
CN104254542A (zh) 2012-03-09 2014-12-31 瑞士杰特贝林生物制品有限公司 包含分泌-样免疫球蛋白的组合物
US9572872B2 (en) 2012-09-09 2017-02-21 Prothera Biologics, Inc. Treatment of disease using inter-alpha inhibitor proteins
US20140206844A1 (en) * 2013-01-18 2014-07-24 Prothera Biologics Methods for isolating blood products from an inter-alpha inhibitor protein-depleted blood product material
CA2916566A1 (fr) 2013-07-05 2015-01-08 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Matrice de chromatographie d'affinite
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
FR3018450B1 (fr) 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
KR101917196B1 (ko) * 2014-03-11 2018-11-09 주식회사 녹십자홀딩스 면역글로불린의 정제방법
US9556253B2 (en) * 2014-12-02 2017-01-31 Hemarus Therapeutics Limited Process for increased yield of immunoglobulin from human plasma
CN121371151A (zh) 2014-12-03 2026-01-23 瑞士杰特贝林生物制品有限公司 具有增加的稳定性的包含免疫球蛋白的药物产品
CA3036553A1 (en) 2016-09-13 2018-03-22 Prothera Biologics, Inc. Methods for treating pulmonary disease using inter-alpha inhibitor proteins
FR3064484A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Composition d'immunoglobulines utiles pour traiter des infections virales
FR3064485A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Traitement d'une infection par le virus respiratoire syncytial
FR3064486A1 (fr) 2017-03-31 2018-10-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Prevention d'une infection par le virus respiratoire syncytial dans les voies respiratoires superieures
KR102587810B1 (ko) 2017-04-25 2023-10-11 프로테라 바이오로직스, 인크. 인터-알파 억제제 단백질을 정량화하는 방법
MX2022011950A (es) 2020-03-31 2022-10-21 Takeda Pharmaceuticals Co Metodo para producir una preparacion de inmunoglobulina a partir de plasma con reduccion del inhibidor de c-1.
JP2024501025A (ja) 2020-12-28 2024-01-10 プラズマ テクノロジーズ エルエルシー 免疫グロブリンｇのプロセススケールでの単離のためのシステム及び方法
CA3236213A1 (en) 2021-10-27 2023-05-04 Eugene ZURLO Compositions and methods for isolating proteins
KR20250161658A (ko) * 2023-03-29 2025-11-17 체에스엘 베링 아게 부작용과 관련된 면역글로불린을 식별하는 방법
AU2024351533A1 (en) 2023-09-26 2026-03-19 Takeda Pharmaceutical Company Limited IMMUNOGLOBULIN FORMULATIONS DEPLETED IN IgA

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7511055A (nl) * 1975-09-19 1977-03-22 Leuven Res & Dev Vzw Trombosetest.
US4136094A (en) * 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin
ES502788A0 (es) * 1981-06-04 1982-04-01 Landerlan Sa Lab Procedimiento de preparacion de imuno globulina g nativa li-bre de actividad anticomplementaria
FR2543448A1 (fr) * 1983-04-01 1984-10-05 Rhone Poulenc Spec Chim Procede de fractionnement du plasma
US4841024A (en) * 1986-09-15 1989-06-20 Becton Dickinson And Company Purification of antibodies
DE3640513A1 (de) * 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
US4806346A (en) * 1986-12-16 1989-02-21 American Home Products Corporation Method for isolation of antigen specific immunoglobulin
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
DE4118912C1 (pt) * 1991-06-08 1992-07-02 Biotest Pharma Gmbh, 6072 Dreieich, De

Also Published As

Publication number Publication date
ES2148332T3 (es) 2000-10-16
FR2706466A1 (fr) 1994-12-23
EP0703922A1 (fr) 1996-04-03
PT703922E (pt) 2000-11-30
DE69424545T2 (de) 2001-01-18
HU9503557D0 (en) 1996-02-28
US6069236A (en) 2000-05-30
HU218463B (hu) 2000-09-28
HUT74272A (en) 1996-11-28
CA2165203C (fr) 2009-08-18
WO1994029334A1 (fr) 1994-12-22
AU7002394A (en) 1995-01-03
JP4218980B2 (ja) 2009-02-04
DE69424545D1 (de) 2000-06-21
JPH09500369A (ja) 1997-01-14
CZ328795A3 (en) 1996-07-17
GR3034177T3 (en) 2000-11-30
DK0703922T3 (da) 2000-11-13
CZ287186B6 (en) 2000-10-11
FR2706466B1 (fr) 1995-08-25
EP0703922B1 (fr) 2000-05-17
CA2165203A1 (fr) 1994-12-22
ATE193020T1 (de) 2000-06-15

Similar Documents

Publication Publication Date Title
DK0703922T3 (da) Fremgangsmåde til fremstilling af immunoglobulin G koncentrat
ATE187462T1 (de) Reinigung von alpha-l-proteinaseinhibitor mittels neuen chromatographischen trennungsbedingungen
ATE190623T1 (de) Verwendung von steroiden zur inhibierung von angiogenesis
PT94869A (pt) Processo de preparacao de uma composicao terapeutica a base de moleculas de anticorpos anti-cd14
DK1378572T3 (da) BMP-11-sammensætninger
DK0626861T4 (da) Behandling af astma.
NO180336C (no) Analogifremgangsmåte for fremstilling av nye, terapeutisk aktive kroman- og tiokromanderivater samt deres mellomprodukter
ATE251668T1 (de) Reinigung von plasmafraktion
DE59208982D1 (de) Verfahren zur Reinigung von IgG-monoklonalen Antikörpern
ATE246248T1 (de) Anti-hiv-proteine gap31, dap30 und dap32, die sie kodierende dna und ihre therapeutische nutzung
ATE192655T1 (de) Verwendung von histamin-gamma-globulin zur herstellung eines immunomodulierenden und antiinflammatorischen agens
BR9301641A (pt) Processo para produzir uma preparacao de fator viii,altamente purificada e uso
PT724600E (pt) Processo de preparacao de um concentrado de inter-alfa-tripsina inibidor para uso terapeutico e concentrado obtido
FI902843A0 (fi) Foerfarande foer framstaellning av renade albuminloesningar.
FI953565A7 (fi) Uusi antikoagulanttikofaktoriaktiivisuus
MX9203011A (es) Procedimiento para preparar una solucion acuosa de fragmento de factor de von willebrand alterado con cisteina y solucion terapeutica fundida mediante el mismo
BR9807598A (pt) Processo de produção para globulina de soro imunológico intravenoso e produto resultante
CA2213577A1 (en) A process for the preparation of factor ix from biological sources
SE7909897L (sv) Rening av gammaglobulinderivat
ATE161732T1 (de) In cyclodextrinen eingeschlossene steroide
DE69012034D1 (de) Monoklonaler Antikörper gegen Exotoxin A von Pseudomonas aeruginosa.
ES2093912T3 (es) Procedimiento para la depuracion de 1,1-dicloro-1-fluoroetano.
IT1247150B (it) Processo per la sintesi e la purificazione del fattore neuronotroficociliare umano (cntf) da escherichia coli.

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
CKFC Appeal: appeal against refusal